Aster Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Aster Capital Management's KNSA Position: Q3 2026 in Review
Aster Capital Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 142 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #766 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in KNSA as recently as Q4 2025.
Aster Capital Management first reported a position in KNSA in Q1 2025 and has held it in 4 quarters since. The position peaked at $592K in Q2 2025. 300 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Aster Capital Management held 142 shares of Kiniksa Pharmaceuticals worth $10.6K as of Q3 2026.
- Kiniksa Pharmaceuticals was a new Aster Capital Management position in Q3 2026.
- Kiniksa Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #766 holding.
- Aster Capital Management first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
- Aster Capital Management's Kiniksa Pharmaceuticals position peaked at $592K in Q2 2025.
- 300 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.